Gadobenate dimeglumine as a contrast agent for MRI of the mouse liver

NMR in Biomedicine

Volumn 20, Issue 8, 2007, Pages 726-732

  Inoue, Yusuke ^a   Yoshikawa, Kohki ^b   Nomura, Yukihiro ^c   Izawa, Kiyoko ^a   Shimada, Morio ^d   Tojo, Arinobu ^a   Ohtomo, Kuni ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b KOMAZAWA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Contrast media; Gadobenate dimeglumine; Liver; MRI

Indexed keywords

ANESTHETICS; CONTRAST MEDIA; PHARMACOKINETICS;

GADOBENATE DIMEGLUMINE; ISOFLURANE ANESTHESIA;

MAGNETIC RESONANCE IMAGING;

CONTRAST MEDIUM; GADOBENATE DIMEGLUMINE; GADOBENIC ACID; ISOFLURANE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EXCRETION; FEMALE; LIVER CLEARANCE; LIVER EXAMINATION; LIVER WEIGHT; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PRIORITY JOURNAL; REPRODUCIBILITY; THREE DIMENSIONAL IMAGING; VOLUMETRY;

ANIMALS; CONTRAST MEDIA; FEMALE; IMAGE PROCESSING, COMPUTER-ASSISTED; KIDNEY; KINETICS; LIVER; MAGNETIC RESONANCE IMAGING; MEGLUMINE; MICE; MICE, INBRED BALB C; ORGANOMETALLIC COMPOUNDS;

MUS;

EID: 37349035289     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1135     Document Type: Article

References (20)

1. Peters MG. Animal models of autoimmune liver disease. Immunol. Cell Biol. 2002; 80: 113-116.
2. Koike K, Moriya K, Kimura S. Role of hepatitis C virus in the development of hepatocellular carcinoma: transgenic approach to viral hepatocarcinogenesis. J. Gastroenterol. Hepatol. 2002; 17: 394-400.
3. Heijstek MW, Kranenburg O, Borel Rinkes IH. Mouse models of colorectal cancer and liver metastases. Dig. Surg. 2005; 22: 16-25.
4. Anstee QM, Goldin RD. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int. J. Exp. Pathol. 2006; 87: 1-16.
5. Nieman BJ, Bock NA, Bishop J, Chen XJ, Sled JG, Rossant J, Henkelman RM. Magnetic resonance imaging for detection and analysis of mouse phenotypes. NMR Biomed. 2005; 18: 447-468.
6. Vittadini G, Felder E, Musu C, Tirone P. Preclinical. profile of Gd-BOPTA: a liver-specific MRI contrast agent. Invest. Radiol. 1990; 25(Suppl. 1): S59-S60.
7. Young SW, Simpson BB, Ratner AV, Matkin C, Carter EA. MRI measurement of hepatocyte toxicity using the new MRI contrast agent manganese dipyridoxal diphosphate, a manganese/pyridoxal 5-phosphate chelate. Magn. Reson. Med. 1989; 10: 1-13.
8. Weinmann HJ, Schuhman-Giampieri G, Schmitt-Willich H, Vogler H, Frenzel T, Gries H, A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI. Magn. Reson. Med. 1991; 22: 233-237.
9. Yoshikawa K, Inoue Y, Akahane M, Shimada M, Itoh S, Seno A, Hayashi S. Phantom and animal studies of a new hepatobiliary agent for MR imaging: comparison of Gd-DTPA-DeA with Gd-EOB-DTPA. J. Magn. Reson. Imaging 2003; 18: 204-209.
10. Haishi T, Uematsu T, Matsuda Y, Kose K. Development of a 1.0 T MR microscope using a Nd-Fe-B permanent magnet. Magn. Reson. Imaging 2001; 19: 875-880.
11. Inoue Y, Nomura Y, Haishi T, Yoshikawa K, Seki T, Tsukiyama-Kohara K, Kai C, Okubo T, Ohtomo K. Imaging of living mice using a 1-T compact magnetic resonance imaging system. J. Magn. Reson. Imaging 2006; 24: 901-907.
12. Petersein J, Spinazzi A, Giovagnoni A, Soyer P, Terrier F, Lencioni R, Bartolozzi C, Grazioli L, Chiesa A, Manfredi R, Marano P, Van Persijn Van Meerten EL, Bloem. JL, Petre C, Marchal G, Greco A, McNamara MT, Heuck A, Reiser M, Laniado M, Claussen C, Daldrup BE, Rummeny E, Kirchin MA, Pirovano G, Hamm B. Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging: a multicenter phase III clinical study. Radiology 2000; 215: 727-736.
13. Vogl TJ, Pegios W, McMahon C, Balzer J, Waitzinger J, Pirovano G, Lissner J. Gadobenate dimeglumine: a new contrast agent for MR imaging: preliminary evaluation in healthy volunteers. AJR Am. J. Roentgenol. 1992; 158: 887-892.
14. Spinazzi A, Lorusso V, Pirovano G, Kirchin M. Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers. Acad. Radiol. 1999; 6: 282-291.
15. Cavagna F, Dapra M, Maggioni F, de Haen C, Felder E. Gd-BOPTA/Dimeg: experimental disease imaging. Magn. Reson. Med. 1991; 22: 329-333.
16. de Haen C, Lorusso V, Tirone P. Hepatic transport of gadobenate dimeglumine in TR-rats. Acad. Radiol. 1996; 3(Suppl. 2): S452-S454.
17. Lorusso V, Arbughi T, Tirone P, de Haen C. Pharmacokinetics and tissue distribution in animals of gadobenate ion, the magnetic resonance imaging contrast enhancing component of gadobenate dimeglumine, 0.5 M solution for injection (Multi-Hance). J. Comput. Assist. Tomogr. 1999; 23(Suppl. 1): S181-S194.
18. Watkins JB III. Exposure of rats to inhalational anesthetics alters the hepatobiliary clearance of cholephilic xenobiotics. J. Pharmacol. Exp. Ther. 1989; 250: 421-427.
19. Garbow JR, Kataoka M, Flye MW. MRI measurement of liver regeneration in mice following partial hepatectomy. Magn. Reson. Med. 2004; 52: 177-180.
20. Inderbitzin D, Gass M, Beldi G, Ayouni E, Nordin A, Sidler D, Gloor B, Candinas D, Stoupis C. Magnetic resonance imaging provides accurate and precise volume determination of the regenerating mouse liver. J. Gastrointest. Surg. 2004; 8: 806-811.